Literature DB >> 1097162

A 10-year experience with subcutaneous mastectomy.

S Fredericks.   

Abstract

Subcutaneous mastectomy appears to remain a procedure of promise. This 10-year experience indicated that it is feasible in at least 80 per cent of selected patients to successfully remove the breast parenchyma and subsequently reconstruct the breast without serious complications. It is resonable to assume that as surgical technique and experience improve, the complication rate will diminish. Furthermore, it is essential that better breast implants be devised and developed in the future. This would clearly enhance all forms of cosmetic breast surgery. The use of subcutaneous mastectomy as a prophylactic cancer procedure will parellel the improvement of implant breast reconstruction. Whether subcutaneous mastectomy will measurably reduce the mortality rate of carcinoma of the breast will, of course, take a generation to determine. However, I have no doubts that is it as justifiable and valuable surgical tool in the treatment of breast disease. The concept of almost total breast biopsy has great merit in the discovery of occult carcinoma. Clearly, caution should be exercised in the selection of cases for this modality, and further study must be devoted to develop diagnostic guidelines of ever-increasing precision to determine which breasts are potentially malignant and should be afforded the procedure.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097162

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  2 in total

1.  A Comparative Analysis between Subpectoral versus Prepectoral Single Stage Direct-to-Implant Breast Reconstruction.

Authors:  Jeong-Hoon Kim; Seung Eun Hong
Journal:  Medicina (Kaunas)       Date:  2020-10-13       Impact factor: 2.430

2.  Prepectoral Direct-to-Implant Breast Reconstruction: Early Outcomes and Analysis of Postoperative Pain.

Authors:  Rafi Fredman; Cindy Wu; Mihaela Rapolti; Daniel Luckett; Jason Fine; Kandace McGuire; Kristalyn Gallagher; Michelle Roughton
Journal:  Aesthet Surg J Open Forum       Date:  2019-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.